ProPhase Labs, Inc. Dividends Per Share
ProPhase Labs, Inc. (PRPH) reported Dividends Per Share of $0.00 per share for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareDeclared · last filed 2023-08-11
- 2023-06-30: Common Stock, Dividends, Per Share, Declared 6 month $0.00.
| Period end | Common Stock, Dividends, Per Share, Declared 6 month |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |